BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24692767)

  • 21. Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis.
    Ayata G; Ithamukkala S; Sapp H; Shaz BH; Brien TP; Wang HH; Antonioli DA; Farraye FA; Odze RD
    Am J Surg Pathol; 2002 Nov; 26(11):1414-23. PubMed ID: 12409717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of Helicobacter pylori eradication on gastroesophageal reflux disease.
    Güliter S; Kandilci U
    J Clin Gastroenterol; 2004 Oct; 38(9):750-5. PubMed ID: 15365399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
    Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.
    Sheu BS; Huang JJ; Yang HB; Huang AH; Wu JJ
    Aliment Pharmacol Ther; 2003 May; 17(10):1283-90. PubMed ID: 12755841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Case of suspicious lansoprazole-associated collagenous colitis in ANCA-associated nephritis].
    Sasatomi Y; Takahata M; Abe Y; Ishimura A; Miyake K; Ogahara S; Murata T; Nakashima H; Maeda K; Saito T
    Nihon Jinzo Gakkai Shi; 2010; 52(2):141-6. PubMed ID: 20415235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple therapy with lansoprazole, clarithromycin, and amoxicillin for the cure of Helicobacter pylori infection: a short report.
    Riff DS; Kidd S; Rose P; Haber M; Weissfeld A; Siepman N
    Helicobacter; 1996 Dec; 1(4):238-42. PubMed ID: 9398874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population.
    Miwa H; Nagahara A; Sato K; Ohkura R; Murai T; Shimizu H; Watanabe S; Sato N
    J Gastroenterol Hepatol; 1999 Apr; 14(4):317-21. PubMed ID: 10207779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diarrhea associated with lansoprazole.
    Mukherjee S
    J Gastroenterol Hepatol; 2003 May; 18(5):602-3. PubMed ID: 12702056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection.
    Bago J; Galović A; Belosić Halle Z; Bilić A; Bevanda M; Bago P
    Wien Klin Wochenschr; 2004 Jul; 116(14):495-9. PubMed ID: 15379146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collagenous Colitis with Escitalopram Use: A Case Report and Literature Review.
    Gray E; Wettergreen SA
    Healthcare (Basel); 2024 Jan; 12(3):. PubMed ID: 38338214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H; Echizen H; Nachi S; Ohnishi A
    Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
    Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK
    Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.
    Miwa H; Yamada T; Sato K; Ohta K; Ohkura R; Murai T; Nagahara A; Takei Y; Ogihara T; Sato N
    Dig Dis Sci; 2000 Jan; 45(1):77-82. PubMed ID: 10695617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocytic and collagenous colitis in children and adolescents: Comprehensive clinicopathologic analysis with long-term follow-up.
    Windon AL; Almazan E; Oliva-Hemker M; Hutchings D; Assarzadegan N; Salimian K; Montgomery EA; Voltaggio L
    Hum Pathol; 2020 Dec; 106():13-22. PubMed ID: 32991931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
    Bazzoli F; Zagari RM; Pozzato P; Fossi S; Ricciardiello L; Nicolini G; De Luca L; Berretti D; Alampi G; Di Pietro C; Morelli P; Roda E
    Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological significance of lymphocytic colitis/collagenous colitis in inflammatory bowel disease.
    Yuan L; Wu TT; Chandan V; Huang Y; Zhang L
    Hum Pathol; 2020 Feb; 96():87-95. PubMed ID: 31698005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microscopic colitis: a descriptive clinical cohort study of 795 patients with collagenous and lymphocytic colitis.
    Mellander MR; Ekbom A; Hultcrantz R; Löfberg R; Öst Å; Björk J
    Scand J Gastroenterol; 2016; 51(5):556-62. PubMed ID: 26679722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection.
    Hagiwara T; Kato M; Anbo T; Imamura A; Suga T; Uchida T; Fujinaga A; Nakagawa M; Nakagawa S; Shimizu Y; Yamamoto J; Takeda H; Asaka M
    World J Gastroenterol; 2007 Jul; 13(28):3836-40. PubMed ID: 17657838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori.
    Sieg A; Sellinger M; Schlauch D; Hörner M; Fuchs W
    Aliment Pharmacol Ther; 1999 Jul; 13(7):865-8. PubMed ID: 10383519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.